For instance, gain-of-function mutations in RyR2 have been shown to predispose to catecholaminergic polymorphic ventricular tachycardia and AF by enhanced propensity for spontaneous Ca(2+) release29. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.